Study on Efficacy of Tramebutin Combined with Microecology in Treating Diarrhea-type Irritable Bowel Syndrome  

作　　者：YAOLu MAWenpei 

机构地区：[1]Hunan Aerospace Hospital, Changsha, Hunan, 430205

出　　处：《外文科技期刊数据库(文摘版)医药卫生》2022年第7期187-190,共4页

摘　　要：Objective: to investigate the efficacy of trimebutine combined with probiotics in the treatment of diarrhea type irritable bowel syndrome. Methods: from July 2020 to July 2021, 100 patients with IBS received in our hospital were randomly divided into experimental group and control group, and then differentiated treatment schemes were implemented according to the situation after grouping. After 4 weeks of treatment, the specific curative effects of the two groups were evaluated from various indicators. Results: the symptom scores of patients before and after treatment were counted and compared between groups. The results showed that there was no significant difference between the two groups in this regard before the start of treatment (P > 0.05), but after treatment, the symptom scores of the experimental group were significantly lower than those of the control group (P < 0.05);The clinical treatment effect of the two groups was observed. The treatment effective rate of the experimental group (94.00%) was significantly higher than that of the control group (72.00%), and the difference between the groups was statistically significant (P < 0.05);The incidence of adverse reactions in the experimental group was significantly lower than that in the control group (P < 0.05). Conclusion: in clinical practice, patients with diarrhea type irritable bowel syndrome can give priority to the treatment scheme of microecological agents combined with trimebutine. This scheme has high safety and reliable curative effect, and is worthy of promotion.

关 键 词：trammebutin MICROECOLOGY diarrhea irritable bowel syndrome EFFICACY 

分 类 号：R[医药卫生]